Aging and oxygen toxicity: Relation to changes in melatonin

Journal of the American Aging Association

Volumn 20, Issue 4, 1997, Pages 201-213

  Reiter, Russel J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINOLEVULINIC ACID; BACTERIUM LIPOPOLYSACCHARIDE; CARBON TETRACHLORIDE; FREE RADICAL; KAINIC ACID; MELATONIN; OXYGEN; PARAQUAT; SAFROLE;

AGING; ANTIOXIDANT ACTIVITY; CHEMICAL REACTION KINETICS; HORMONE RELEASE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; OXYGEN TOXICITY; REVIEW;

EID: 0031545524     PISSN: 01619152     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11357-997-0020-2     Document Type: Article

References (126)

1. Harman, D.: Aging: A theory based on free radicals and radiation chemistry. J. Gerontol. 11:298-300, 1956
2. Harman, D.: Free radical theory of aging: Origin of life, evolution, and aging. Age 3:100-102, 1980.
3. Hayflick, L.: Theories of biological aging. Exp. Gerontol. 20: 145-159, 1985.
4. Rose, M.R.: The Evolutionary Biology of Aging. New York, Oxford, 1991, 221pp.
5. Harman, D.: Free radical theory of aging: The "free radical" related diseases. Age 7:111-131, 1983.
6. Harman, D.: The aging process: Major risk factor for disease and death. Proc. Natl. Acad. Sci. USA 88: 5360-5633,1991.
7. Kehrer, J.P.: Free radicals, mediators of tissue injury and disease. Crit. Rev. Toxicol. 23: 21-48. 1993.
8. Ames, B.N., Shigenaga, M.K.: Oxidants are a major contributor to cancer and aging, in DNA and Free Radicals, edited by Halliwell, H., and Aruoma, O., London, Ellis Harwood, 1993, pp. 1-18.
9. Reiter, R.J., Tan, D.X., Poeggeler, B., Menendez-Pelaez, A., Chen, L.C., Saarela, S.: Melatonin as a free radical scavenger: Implications for aging and age-related diseases Ann. N.Y. Acad. Sci. 719: 1-12, 1994.
10. Reiter, R.J.: Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9:526-533, 1995.
11. Halliwell, B., Gutteridge, J.M.C.: Oxygen toxicity, oxygen radicals, transitional metals and disease. Biochem. J. 219: 1-14, 1984.
12. Kehrer, J.P., Smith, C.V.: Free radicals in biology: Sources. reactivities and roles in the etiology of human disease, in Natural Antioxidants in Human Health and Disease, edited by Frei, B., San Diego, Academic Press, 1994. pp. 25-62.
13. Sies, H.: Strategies of antioxidative defense. Eur. J. Biochem. 215: 213-219. 1993.
14. McCord, J.M., Omar, B.A.: Sources of free radicals. Toxicol. Indust. Health. 9: 23-37, 1993.
15. Fridovich, I: Superoxide dismutases: An adaptation to a paramagnetic gas. J. Biol. Chem. 264: 7761-7764, 1989.
16. Tyler, D.D.: Polargraphic assay and intracellular distribution of superoxide dismutase in rat liver. Biochem. J. 147: 493-504, 1975.
17. Curnutte, J.T., Babior, B.M: Chronic granulomatous disease. Adv. Human Genet. 16:229-297, 1987.
18. Colton, C.A., Gilbert, D.L.: Production of superoxide anions by a CNS macrophage, the microglia. FEES Lett. 223: 284-288, 1987.
19. Schreck, R., Bauerle, R.A.: A role for oxygen radicals as second messengers. Trends Cell Biol. 1: 39-42, 1991.
20. Fridovich, I: The biology of oxygen radicals. Science 201: 875-880, 1978.
21. Diplock, A.T.: Antioxidants and free radical scavengers, in Free Radical Damage and its Control, edited by Rice-Evans, C.A., Burdan, R.H., Amsterdam, Elsevier, 1994, 113-130.
22. Lejeune, J.: Pathogenesis of mental deficiency in Parkinson's disease. J. Med. Genet. 7(Suppl.):20-30, 1990.
23. Bowling, A.C., Schulz, J.B., Brown, R.H., Jr., Beal, M.F.: Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61: 2322-2325, 1993.
24. Olanow, C.W.: Oxidative reactions in Parkinson's disease. Neurology 40 (Suppl. 3): 32-37, 1990.
25. Boveris, A., Oshino, N., Chance, B.: The cellular production of hydrogen peroxide. Biochem. J. 128: 617-630, 1972.
26. Chance, B., Sies, H., Boveris, A.: Hydroperoxide metabolism in mammalian organs. Physical Rev. 59: 527-605, 1979.
27. Jain, A., Martensson, J., Stole, E., Auld. P.A.M., Meister, A.: Glutathione deficiency leads to mitochondrial damage in brain. Proc. Nat. Acad. Sci. USA 88: 1913-1917, 1991.
28. Gerschmann, R., Gilbert, D.L., Nye, S.W., Dwyer, P., Fenn, W.O.: Oxygen poisoning and X-irradiation: A mechanism in common. Science 119: 623-626, 1954.
29. Moncada, S., Palmer, R.M.I., Higgs, E.A.: Nitric oxide: Physiology. pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
30. Radi, R., Bedsman, J.S., Buch, K.M. Freeman, B.A.: Peroxynitrite oxidation by sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266: 4244-4250, 1991.
31. Van der Vliet, M., O'Neill, C.A., Halliwell, B., Cross, C.E., Kaun, H.: Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite: Evidence for hydroxyl radical production from peroxynitrite. FEBS Lett. 339: 89-92, 1994.
32. Laurindo, F.R.M., de Luz, P.L., Uint, L., Rocha, T.F., Jaeger, R.G., Lopes, E.A.: Evidence for superoxide radical-dependent coronary vasopasm after angioplasty in intact dogs. Circulation 83: 1705-1715, 1991.
33. Spector, A.: The lens and oxidative stress, in Oxidative Stress, Oxidants and Antioxidants, edited by Sies, H., San Diego, Academic Press, 1993, pp. 529-558.
34. Wendel, A., Niehorster, M., Tregs, G: Interactions between reactive oxygen and mediators of sepsis and shock, in Oxidative Stress, Oxidants and Antioxidants, edited by Sies, H., San Diego, Academic Press, 1993, 685-594.
35. Schwartz, C.J., Valente, A.J.: The pathogenesis of atherosclerosis, in Natural Antioxidants in Human Health and Disease, edited by Frei, B., San Diego, Academic Press, 1994, pp. 287-302.
36. Poeggeler, B., Reiter, R.J., Tan, D.X., Chen, L.D., Manchester, L.C.: Melatonin, hydroxyl radical-mediated oxidative damage and aging. J. Pineal Res. 14: 151-158, 1993.
37. Harman, D.: Free radical theory of aging: Alzheimer's disease pathogenesis. Age 18: 97-119, 1995.
38. Harman, D.: Free-radicals and age-related diseases, in Free Radicals and Aging, edited by Yu, B.P., Boca Taton. CRC Press, 1993, pp. 205-222.
39. Shigenaga, M.K., Ames, B.N.: Oxidanis and mitochondrial decay in aging, in Natural Antioxidants in Human Health and Disease, edited by Frei, B., 1994, pp. 63-106.
40. McCay, C.M. Crowell, M.F., Manard, L.A.: The effect of retarded growth upon the length of lifespan and upon ultimate body size. J. Nutr. 10: 63-75, 1935.
41. Kristal, B.S., Yu, B.P.: Aging and its modulation by dietary restriction, in Modulation of Aging Processes by Dietary Restriction, edited by Yu. B.P., Boca Raton. CRC Press. 1994, pp. 1-36.
42. Keaney, J.F., Jr., Frei, B.: Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease, in Natural Antioxidants in Human Health and Disease, edited by Frei, B., San Diego, Academic Press, 1994. pp. 303-354.
43. Byers, T., Guerrero, N.: Epidemiologic evidence for vitamin C and E in cancer prevention. Am. J. Clin. Nutr. 62 (Suppl): 13855-13935, 1995.
44. Brivba, K., Sies, H.: Non enzymatic antioxidant defense systems, in Natural Antioxidants in Human Health and Disease, edited by Frei, B., San Diego, Academic Press, 1994, pp. 107-128.
45. Niki, E., Noguchi, N., Tsuchinashi, H., Gotoh, N.: Interaction among vitamin C, vitamin E, and β-carotene. Am. J. Clin. Nitr. 62 (Suppl): 1322S-1326S, 1995.
46. Matsuo, M.: Age-related alterations in antioxidant defense, in Free Radicals and Aging, edited by Yu, B.P., Boca Raton, CRC Press, 1993, pp. 143-182.
47. Reiter, R.J., Melchiorri, D., Sewerynek, E., Poeggeler, B., Barlow-Walden, L.R., Chuang, J.I., Ortiz, G.G., Acuña-Castroviejo, D.: A review of the evidence supporting melatonin's role as an antioxidant J. Pineal Res. 18: 1-11, 1995.
48. Ianas, O., Olnescu, R., Badescu, I.: Melatonin involvement in oxidative stress. Rom. J. Endocrinol. 29: 147-153, 1991.
49. Tan, D.X., Chen, L.D., Poeggeler, B., Manchester, L.C., Reiter, R.J.: Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocrine J. 1: 57-60, 1993.
50. Sies, H., Stahl, W.: Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr. 62 (Suppl.): 1315S-1321S, 1995.
51. Pieri,C., Marra, M., Moroni, F., Recchioni, R., Marcheselli, F.: Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci. 55: PL271-PL27, 1994.
52. Pieri C., Moroni, M., Marra, M., Marcheselli, F., Recchioni, R.: Melatonin as an efficient antioxidant. Arch. Gerontol. Genatr. 20: 159-165, 1995.
53. Scaiano, J.C.: Exploratory laser flash photolysis study of free radical reactions and magnetic field effects in melatonin chemistry. J. Pineal Res. 19: 189-195, 1995.
54. Marshall, K.A., Reiter, R.J., Poeggeler, B., Auroma, O.I., Halliwell, B.: Evaluation of the antioxidant activity of melatonin in vitro. Free Rad. Biol. Med. 21: 307-315, 1996.
55. Chan; T Y., Tang, P.C.: Characterization of the antioxidant effects of melatonin and related indoleamines in vitro. J. Pineal Res. 20: 187-191, 1996.
56. Reiter, R.J.: Oxygen radical detoxification processes during aging: The functional importance of melatonin. Aging Clin. Exp. Res. 7:340-351, 1995.
57. Reiter, R.J.: Antioxidant actions of melatonin. Adv. Pharmacol. 38: 103-117, 1997.
58. Reiter, R.J., Pablos, M.I., Agapito, T.T., Guerrero, J.M.: Melatonin in the context of the free radical theory of aging. Ann. N.Y. Acad. Sci. 786: 362-378, 1996.
59. Pierrefiche, G., Laborit, H.: Oxygen radicals, melatonin and aging. Exp. Gerontol. 30: 213-227, 1995
60. Sewerynek, E., Melchiorri, D., Chen, L.D., Reiter, R.J.: Melatonin reduces both basal and bacterial lipopolysaccaride-induced lipid peroxidation in vitro. Free Rad. Biol. Med. 19: 903-909, 1995.
61. Daniels, W.M.U., Reiter, R.J., Melchiorri, D., Sewerynek, E., Pablos, M.I., Ortiz, G.G.: Melatonin counteracts lipid peroxidation induced by carbon tetrachloride but does not restore glucose-6-phosphatase activity. J. Pineal Res. 19: 1-6, 1995.
62. Melchiorri, D., Reiter, R.J., Attia, A.M., Hara, M., Burgos, A., Nistico, G.,: Potent portective effect of melatonin on in vivo paraquat induced oxidative damage in rats. Life Sci. 56: 83-89, 1995.
63. Tan, D.X., Poeggeler, B., Reiter, R.J., Chen, L.D., Chen, S., Manchester, L.C., Barlow-Waiden, L.R.: The pineal hormone melatonin inhibits DNA adduct formation induced by the carcinogen safrole in vivo. Cancer Lett. 70: 65-71, 1993.
64. Tan, D.X., Reiter, R.J., Chen, L.D., Poeggeler, B., Manchester, L.C., Barlow-Walden, L.R.: Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15:215-218, 1994.
65. Vijayalaxmi, Reiter, R.J., Sewerynek, E., Poeggeler, B., Leal, B.Z., Meltz, M.: Marked reduction of radiation-induced micronuclei in human blood lymphoocytes pretreated with melatonin. Radiat. Res. 143: 102-106, 1995.
66. Cagnoli, C.M., Atabay, C., Kharlamov, E., Mavez, H.: Melatonin protects neurons from singlet oxygen-induced apoptosis. J. Pineal Res. 18: 222-226, 1995.
67. Abe M., Reiter, R.J. Orhii, P.B., Hara, M., Poeggeler, B.: Inhibitory effect of melatonin on cataract formation in newborn rats: Evidence for an antioxidative role for melatonin. J. Pineal Res. 17: 94-100, 1994.
68. Menendez-Pelaez, A., Poeggeler, B., Reiter, R.J., Barlow-Walden, L.R., Pablos, M.I., Tan, D.X.: Nuclear localization of melatonin in different mammalian tissues: Immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 53: 372-382, 1993.
69. Costa, E.J. X., Harzer Lopez, R., Lamy-Freund, M.T.: Permeability of pure lipid bilayers to melatonin. J. Pineal Res. 19: 123-126, 1995.
70. Shida, C.S., Castrucci, A.M.L., Lamy-Freund, M.T.: High melatonin solubility in water. J. Pineal Res. 16: 198-201, 1994.
71. Giusti, P., Gusella, M., Lipartiti, M., Milani, D., Zhu, W. Vicini, S., Manev, H.: Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity. Exp. Neurol. 133: 39-46, 1995.
72. Melchiorri, D., Reiter, R.J., Sewerynek, E., Chen, L.D., Nistico, G.: Melatonin reduces kainate induced lipid peroxidation in homogenates of different brain regions. FASEB J. 9: 1205-1210, 1995.
73. Giusti, P., Lipartiti, M., Franeschini, D., Schiavo, N., Floreani, M., Manev, H.: Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J, 10: 891-896, 1996.
74. Chen, L.D., Melchiorri, D., Sewerynek, E., Reiter, R.J.: Retinal lipid peroxidation in vitro is inhibited by melatonin, Neurosci. Res. Commun. 17: 151-158, 1995.
75. 2 induced lipid peroxidation in homogenates of different rat brain regions. J. Pineal Res. 19: 51-56, 1995.
76. Yamamoto, H.A., Tang, H.W.: Preventive effect of melatonin against cyanide-induced seizures and lipid peroxidation in mice. Neurosci. Lett. 207: 89-92, 1996.
77. Sewerynek, E., Abe, M., Reiter, R.J., Barlow-Walden, L.R., Chen, L.D., McCabe, T.J., Roman, L.J., Diaz-Lopez, B.: Melatonin administration prevents lipopolysaccharide-induced oxidative damage in phenobarbital treated rats. J. Cell. Biochem. 58: 436-444, 1995.
78. Sewerynek, E., Melchorri, D., Reiter, R.J., Ortiz, G.G., Lewinski, A.: Lipopolysaccaride-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur. J. Pharmacol. 293: 327-344, 1995.
79. Sokol, R.J., Devereaux, M.W., Straka, M.S., Everson, G.: Melatonin attenuates hydrophobic bile acid toxicity to isolated rat hepatocytes. Hepatology (Suppl) 24 (No. 4, pt. 2): 338A, 1996.
80. Vijayalaxmi, Reiter, R.J., Meltz, M.: Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mut. Res. 346: 23-31, 1995.
81. Bertuglia, S., Marchiafava, P.L., Colantuoni, A.: Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc. Res. 31:947-952, 1996.
82. Sewerynek, E., Reiter, R.J., Melchiorri, D., Ortiz, G.G., Lewinski, A.: Oxidative damage in the liver induced by ischemia-reperfusion: Protection by melatonin. Hepato-Gastroenterology 43: 898-903, 1996.
83. Manev, H., Uz, T., Kharlamov, Joo, J.Y.: Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J. 10: 1546-1551, 1996.
84. Acuña-Castroviejo, D., Coto-Montes, A., Monti, M.G., Ortiz, G.G., Reiter, R.J.: Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci., 60:PL23-PL29, 1996.
85. + damaged dopamine neurons from cell death in culture. Abst. 26th Ann. Mtg. Soc. Neurosci. 22(pt.1): 742, 1996.
86. Pappolla, M.A., Sos, M., Bick, R.J., Omar, R.A., Hickson-Bick, D.L.M., Reiter, R.J., Efthimiopoulos, S., Sambamurti, K., Robakis, N.K.: Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci., 17:1683-1690, 1997.
87. Richardson, J.S., Zhou, Y.: Oxidative stress in the production and expression of neurotoxic b-amyloid. Restor. Neurol. Neurosci. 9: 207-211, 1996,
88. Reiter, R.J.: Pineal function during aging: Attenuation of the melatonin rhythm and its neurobiologi-cal consequences. Acta Neurobiol. Exp. 54(Suppl.): 31-39, 1994.
89. Reiter, R.J.: The pineal gland and melatonin in relation to aging: A summary of the theories and of the data. Exp. Gerontol. 30: 199-212, 1995.
90. Reiter, R.J.: The aging pineal gland and its physiological consequences. Bio Essays 14:169-175, 1992.
91. Touitou, Y., Fevre, M., Lagugvey, M., Carayon, A., Boydon, A., Reinhart A: Age and mental health related circadian rhythms of plasma levels of melatonin, prolactin, Iuteinizing hormone and follicle stimulating hormone. J. Endocrinol. 91:467-475, 1981.
92. Iguchi, H., Kato, K., Ibayashi, H.: Age-dependent reduction is serum melatonin concentrations in healthy human subjects. J. Clin. Endocrinol. Metab. 55:27-19, 1982.
93. Nair, N.P.V., Haribarasubramanian, N., Pilapil, C., Isaac, I., Thavundayil, J.X.: Plasma melatonin - An index of brain aging in humans? Biol. Psychiatry 21:141-150, 1986.
94. Sack, R.L., Lewy, A.J., Erb, D.L., Vollmer, W.M., Singer, C.M.: Human melatonin production decreases with age. J. Pineal Res. 3:379-388, 1986.
95. Reiter, R.J., Craft, C.M., Johnson, U.E., Jr., King, T.S., Richardson, B.A., Vaughan, G.M., Vaughan, M.K.: Age-associated reduction in nocturnal melatonin levels in female rats. Endocrinology 109:1295-1297, 1981.
96. Pang, S.F., Tang, F., Tang, P.L.: Negative correlations of age and levels of pineal melatonin, pineal N-acetylserotonin and serum melatonin in male rats. J. Exp. Zool. 229:41-47, 1984.
97. Reiter, R.J., Johnson, L.Y., Steger, R.W., Richardson, B.A., Petterborg, L.J.: Pineal biosynthetic activity and neuroendocrine physiology in the aging hamster and gerbil. Peptides (Suppl. 1) 1:69-77, 1980.
98. Reiter, R.J., Richardson, B.A., Johnson, L.Y., Ferguson, B.N., Dinh, D.T.: Pineal melatonin rhythm: Reduction in aging Syrian hamsters. Science 210:1372-1373, 1980.
99. Reiter, R.J., Vriend, J., Brainard, G.G., Matthews, S.A., Craft, C.M.: Reduced pineal and plasma melatonin levels and gonadal atrophy in old hamsters kept under winter photoperiods. Exp. Aging Res. 8:27-30, 1982.
100. Wetterberg, L.: Genetic regulation of melatonin excretion in urine. Clin. Genet. 24:399-402, 1983.
101. Waldhauser, F., Ehrhart, B., Förster, E.: Clinical aspects of the melatonin action: Impact on development, aging and puberty, involvement of melatonin in psychiatric diseases and importance of neuroimmunoendocrine interactions. Experientia 49:671-681, 1993.
102. Maestroni, G.J.M.: The immunoneuroendocrine role of melatonin. J. Pineal Res. 14:1-10, 1993.
103. Masoro, E.J.: Food restriction in rodents: An evaluation of its role in aging. J. Gerontol. 43:B59-B64, 1988.
104. Stokkan, K.A., Reiter, R.J., Nonaka, K.O., Lerchl, A., Yu, B.P., Vaughan, M.K.: Food restriction retards aging of the pineal gland. Brain Res. 545:66-72, 1991.
105. Henden, T., Stokkan, K.A., Reiter, R.J., Nonaka, K.O., Lerchl, A., Jones, D.J.: The age-associated reduction in pineal β-adrenergic receptor density is prevented by life-long food restriction in rats. Biol. Signals 1:34-39, 1992.
106. Axelrod, J.: The pineal gland: A neurochemical transducer. Science 184:1341-1349, 1974.
107. Reiter, R.J., Barlow-Walden, L.R., Poeggeler, B., Heiden, S.M., Clayton, R.J.: Twenty-four hour urinary excretion of 6-hydroxymelatonin sulfate in Down syndrome subjects. J. Pineal Res. 20:45-50, 1996.
108. Street, C.A., Di, W.L, Peneston-Bird, J.F., Patel, S., Sadler, P., Silman, R.E.: The purification and characterization of biological 6-sulfatoxymelatonin and comparison with synthetic 6-sulfatoxymelatonin. J. Pineal Res. 20:98-114, 1996.
109. Medeiros, M.H.G., Marchiori, P.E., Bechara, E.J.H.: Superoxide dimutase, glutathione peroxidase and catalase activities in the erythrocytes of patients with intermittent acute porphyria. Clin. Chem. 31:1673-1676, 1985.
110. Puy, H., Reybach, J.C., Baudry, P., Callebert, J., Touitou, Y., Nordmann, Y.: Decreased nocturnal plasma melatonin levels in patients with recurrent acute intermittent porphyria attacks. Life Sci. 53:621-627.
111. Puy, H., Deyback, J.C., Bogdan, A., Collebert, J., Baumgarter, M., Voisin, P., Nordmann, Y.,Touitou, Y.: Increased δ-aminolevulinic acid and decreased pineal melatonin production: A common event in acute porphyria studies in the rat. J. Clin. Invest. 53:104-111, 1996.
112. Pappolla, M.A., Omar, R.A., Kim, K.S., Robakis, N.K.: Immunohistochemical evidence of oxidative stress in Alzheimer's disease. Am. J. Pathol. 140:621-628.
113. Harris, M.E., Hensley, K., Butterfield, D.A., Leedle, R.A., Carney, J.M.: Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid (1-40) peptide in cultured hippocampus neurons. Exp. Neurol. 131:193-202, 1995.
114. Adams, J.D., Odunze, I.N.: Oxygen free radicals and Parkinson's disease. Free Rad. Biol. Med. 10:161-169, 1991.
115. Olanow, C.W.: An introduction to the free radical hypothesis in Parkinson's disease Ann. Neurol. 32:S2-S9, 1992.
116. Pappolla, M., Sos, M., Bick, R.J., Omar, R.A., Hickson-Bick, D.L.M., Reiter, R.J. Efthimiopoulos, S., Sambamurrti, K., Robakis. N.K.: Oxidative damage and cell death induced by amyloid peptide fragment is completely prevented by melatonin, in Alzheimer's Disease: Biology, Diagnosis and Therapeutics. edited by lgbal, K. Winkblad, B., Nishimura, T., Takeda, M., Wisniewski, H.M., New York, John Wiley, 1997, pp. 741-749.
117. Sainz, R.M., Mayo, J.C., Aria, H., Kotler, M., Antolin, I., Rodriquez, C., Menendez-Pelaez, A.: The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J. Pineal Res. 19:178-188, 1995.
118. Skene, D.J., Vivien-Roels, B., Sparks, D.L., Hunsaker, U.C., Pevet, P., Ravid, D., Swaab, D.F.: Daily variation in the concentration of melatonin and 5-methoxytryplophol in the human pineal gland: Effect of age and Alzheimer's disease. Brain Res. 528:170-174, 1990.
119. Miller, J.W., Selhub, J. Joseph, J.A.: Oxidative damage caused by free radicals produced during catecholamine autooxidation: Protective effect of 0-methylation and melatonin. Free Radical Biol. Med. 21:241-249, 1996.
120. Sundstrom, E., Stromberg, I., Tsutsumi, T., Olson, L., Jonsson, G.: Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57B1/6 mice: Comparison with three other strains of mice. Brain Res. 805:26-38, 1987.
121. Rojas, P., Rios, C.: Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice. Pharmacol Toxicol. 72:364-368, 1993.
122. Armstrong, S.M., Redman, J.R.: Melatonin and circadian rhythmicity, in Melatonin edited by Yu, H.S., and Reiter, R.J., Boca Raton, CRC Press, 1993, pp. 187-224.
123. Dawson, P., Encel, N.: Melatonin and sleep in humans, J. Pineal Res. 15:1-12, 1993.
124. Acuña-Castroviejo, D., Escames, G., Macias, M., Muñoz-Hoyos, A., Molina Carbello, A., Arauzo, M., Montes, R., Vines, F.: Cell protective role of melatonin in the brain. J. Pineal Res. 19:56-63, 1995.
125. Ben-Nathan, D., Maestroni, G.J.M., Lustig, S., Conti, A.: Protective effects of melatonin in mice infected with encychalitis viruses. Arch. Virol. 140:223-230, 1995.
126. Ellis, L.C.: Melatonin reduces mortality from Aleutian disease in mink (Mustela vison). J. Pineal Res., 21: 214-217, 1996.